Amgen Fights Dismissal Bid In Del. Biosimilar Drug Case
A Pfizer Inc. subsidiary urged a federal judge in Delaware on Tuesday to toss a claim that it failed to share full information about a potential new product similar to an...To view the full article, register now.
Already a subscriber? Click here to view full article